News & Updates
Filter by Specialty:
Chronic hepatitis C tied to cardiovascular events in T2DM
19 Jul 2022
In patients with type 2 diabetes mellitus (T2DM), chronic hepatitis C and fatty liver appear to worsen the risk of cardiovascular events, a recent Taiwan study has found.
Chronic hepatitis C tied to cardiovascular events in T2DM
19 Jul 2022Cannabidiol shots safe but of no benefit in drug-resistant focal epilepsy
18 Jul 2022
In the treatment of patients with drug-resistant focal epilepsy, transdermally administered cannabidiol is well tolerated but is not superior to placebo in terms of reducing seizure frequency, according to a study.
Cannabidiol shots safe but of no benefit in drug-resistant focal epilepsy
18 Jul 2022Resmetirom demos potential in NASH
18 Jul 2022
byRoshini Claire Anthony
Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.